Literature DB >> 20647552

Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene.

Merel S Ebberink1, Barbara Csanyi, Wui K Chong, Simone Denis, Peter Sharp, Petra A W Mooijer, Conny J M Dekker, Claire Spooner, Lock H Ngu, Carlos De Sousa, Ronald J A Wanders, Michael J Fietz, Peter T Clayton, Hans R Waterham, Sacha Ferdinandusse.   

Abstract

BACKGROUND: Zellweger syndrome spectrum disorders are caused by mutations in any of at least 12 different PEX genes. This includes PEX16, which encodes an integral peroxisomal membrane protein involved in peroxisomal membrane assembly. PEX16-defective patients have been reported to have a severe clinical presentation. Fibroblasts from these patients displayed a defect in the import of peroxisomal matrix and membrane proteins, resulting in a total absence of peroxisomal remnants.
OBJECTIVE: To report on six patients with an unexpected mild variant peroxisome biogenesis disorder due to mutations in the PEX16 gene. Patients presented in the preschool years with progressive spastic paraparesis and ataxia (with a characteristic pattern of progressive leucodystrophy and brain atrophy on MRI scan) and later developed cataracts and peripheral neuropathy. Surprisingly, their fibroblasts showed enlarged, import-competent peroxisomes.
RESULTS: Plasma analysis revealed biochemical abnormalities suggesting a peroxisomal disorder. Biochemical variables in fibroblasts were only mildly abnormal or within the normal range. Immunofluorescence microscopy revealed the presence of import-competent peroxisomes, which were increased in size but reduced in number. Subsequent sequencing of all known PEX genes revealed five novel apparent homozygous mutations in the PEX16 gene.
CONCLUSIONS: An unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene, with a relatively mild clinical phenotype and an unexpected phenotype in fibroblasts, was identified. Although PEX16 is involved in peroxisomal membrane assembly, PEX16 defects can present with enlarged import-competent peroxisomes in fibroblasts. This is important for future diagnostics of patients with a peroxisomal disorder.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647552     DOI: 10.1136/jmg.2009.074302

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  35 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

2.  Zellweger Spectrum Disorder with Mild Phenotype Caused by PEX2 Gene Mutations.

Authors:  Andrea Mignarri; Claudia Vinciguerra; Antonio Giorgio; Sacha Ferdinandusse; Hans Waterham; Ronald Wanders; Enrico Bertini; Maria Teresa Dotti; Antonio Federico
Journal:  JIMD Rep       Date:  2012-01-29

3.  Clinical utility gene card for: Zellweger syndrome spectrum.

Authors:  Hendrik Rosewich; Hans Waterham; Bwee Tien Poll-The; Andreas Ohlenbusch; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

Review 4.  Peroxisome Biogenesis Disorders.

Authors:  Masanori Honsho; Kanji Okumoto; Shigehiko Tamura; Yukio Fujiki
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.

Authors:  Matthis Synofzik; Rebecca Schüle
Journal:  Mov Disord       Date:  2017-02-14       Impact factor: 10.338

6.  PEX16 contributions to peroxisome import and metabolism revealed by viable Arabidopsis pex16 mutants.

Authors:  Sarah E Burkhart; Roxanna J Llinas; Bonnie Bartel
Journal:  J Integr Plant Biol       Date:  2019-04-03       Impact factor: 7.061

7.  Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.

Authors:  David Cheillan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.

Authors:  Małgorzata Rydzanicz; Teresa Joanna Stradomska; Elżbieta Jurkiewicz; Ewa Jamroz; Piotr Gasperowicz; Grażyna Kostrzewa; Rafał Płoski; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2017-10-18       Impact factor: 3.240

9.  Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood.

Authors:  Chihiro Ohba; Hitoshi Osaka; Mizue Iai; Sumimasa Yamashita; Yume Suzuki; Noriko Aida; Nobuyuki Shimozawa; Ayumi Takamura; Hiroshi Doi; Atsuko Tomita-Katsumoto; Kiyomi Nishiyama; Yoshinori Tsurusaki; Mitsuko Nakashima; Noriko Miyake; Yoshikatsu Eto; Fumiaki Tanaka; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Neurogenetics       Date:  2013-10-04       Impact factor: 2.660

Review 10.  Clinical exome sequencing in neurogenetic and neuropsychiatric disorders.

Authors:  Brent L Fogel; Hane Lee; Samuel P Strom; Joshua L Deignan; Stanley F Nelson
Journal:  Ann N Y Acad Sci       Date:  2015-08-06       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.